WS #1281
The data window reveals a critical escalation in Middle East geopolitical tensions, with multiple high-signal sources corroborating Israeli strikes in Iran. Breaking reports from jetstream.bsky.priority indicate the killing of Iranian leader Ali Larijani and attacks on strategic sites in Shiraz, directly impacting global energy security. This aligns with Al Jazeera's coverage blaming US-Israel for disruptions in the Strait of Hormuz, where oil prices have surged 2.5% to $105.70, and UN warnings of record hunger if the conflict continues. The geopolitical bearishness is partially countered by ongoing diplomatic efforts, as reported by The Guardian, with UK security adviser Jonathan Powell judging a US-Iran nuclear deal was within reach, suggesting potential de-escalation. Corporate developments show mixed signals: Oklo's rally continues after securing regulatory approvals, while insider cluster sells at Ouster, Vicor Corp, and United Therapeutics add pressure. Options activity in TSM shows aggressive institutional rotation with $90M-$140M call sweeps, indicating volatility expectations. Analyst actions include Piper Sandler raising CRISPR Therapeutics' price target to $110 and Cantor Fitzgerald reiterating NVIDIA's Overweight rating at $300, providing sector-specific bullish cues.
Key developments
- Israeli strikes kill Iranian leader Ali Larijani and hit strategic sites in Shiraz
- Al Jazeera reports Iran blames US-Israel for Strait of Hormuz disruptions, oil prices up 2.5% to $105.70
- UK security adviser judged US-Iran nuclear deal was within reach before strikes
- Oklo shares soar after securing U.S. NRC license and DoE agreement for Aurora Powerhouse
- Piper Sandler reiterates Overweight on CRISPR Therapeutics, raises price target to $110
- Heavy options activity in TSM with $90M-$140M call sweeps expiring March 20
- Insider cluster sells at Ouster ($1.4M), Vicor Corp ($15.2M), and United Therapeutics ($15.4M)